Skip to content

Primary Immunodeficiencies and Obstetrical Neuraxial Anaesthesia

Infectious Complications Associated With the Use of Peri-partum Neuraxial Anaesthesia in Patients With Primary Immunodeficiencies

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06449066
Acronym
ANEU-DIP
Enrollment
30
Registered
2024-06-07
Start date
2024-08-08
Completion date
2024-08-20
Last updated
2025-09-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infectious Complications (Epidural Abscess or Meningitis), Obstetrical Neuraxial Anaesthesia

Keywords

Primary immunodeficiencies, Neuraxial anaesthesia, Obstetrical anaesthesia, Epidural abscess, Meningitis

Brief summary

The purpose of this study is to evaluate if neuraxial anesthesia (epidural or intradural anesthesia) used during childbirth is associated with more frequent infectious complications in patients with primary immunodeficiencies (PID).

Detailed description

Neuraxial anaesthesia (epidural or intradural) is often used to alleviate pain during labour and childbirth. Although extremely efficient and safe, rare but serious infectious complications such as epidural abscess or meningitis can occur afterwards. Patients with PID tend to have a greater risk of infectious complications than the general population. With the progress of medical care in those pathologies, female patients are now giving birth more often. The use of neuraxial anaesthesia and the associated infectious complications have never been studied in this population. The investigators intend to review the medical records of PID patients who gave birth in an APHP hospital in the last 10 years to evaluate the use of neuraxial anesthesia and the frequency of infectious complications associated with neuraxial anesthesia.

Interventions

Non applicable (data collection)

Sponsors

URC-CIC Paris Descartes Necker Cochin
CollaboratorOTHER
Assistance Publique - Hôpitaux de Paris
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Female patient included in the CEREDIH national register * Aged \> 18 years

Exclusion criteria

* Refuse to participate * Deceased * Minor * under judicial protection * obstetric file not available

Design outcomes

Primary

MeasureTime frameDescription
Number of participants who develop a local or systemic infection, such as an epidural abscess or meningitis, within 28 days after receiving neuraxial anesthesia during delivery28 days post-partumOccurrence of a local or systemic infection post-neuraxial anesthesia within 28 days after delivery / Infectious complication after obstetrical neuraxial anesthesia / Epidural abscess or meningitis after neuraxial anesthesia

Secondary

MeasureTime frameDescription
Frequency of Alternative Pain Relief Methods Utilized Due to Contraindications Linked to Primary ImmunodeficiencyDuring labourUse of an alternate method for pain-relief during childbirth / Use of another method of pain relief due to a contraindication linked to primary immunodeficiency
Rate of Antibioprophylaxis Administration During Neuraxial Anesthesiaup to 24 hours after birthUse of a antibioprophylaxis when performing neuraxial anesthesia
Number of cases where maternity anesthetists identify contraindications to performing neuraxial anesthesia in patients with primary immunodeficiencyDuring labourPossible occurrence of contraindications identified by the maternity anesthetist to the performance of neuraxial anesthesia linked to primary immunodeficiency

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 6, 2026